These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2652501)

  • 21. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract]   [Full Text] [Related]  

  • 23. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
    Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 25. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

  • 26. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipients.
    Venning MC; Lennard TW; Stevens ME; Proud G; Ward MK; Elliott RW; Taylor RM; Wilkinson R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1633-4. PubMed ID: 2652533
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
    Schulak JA; Moritz CE; Hricik DE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV; Andersen RC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal graft histology in patients treated with different doses of cyclosporine.
    Wilczek HE; Bohman SO; Groth CG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 33. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
    Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
    Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
    [No Abstract]   [Full Text] [Related]  

  • 35. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract]   [Full Text] [Related]  

  • 36. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 37. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth.
    Hodson EM; Knight JF; Sheil AG; Roy LP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 40. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.